Market revenue in 2023 | USD 12.9 million |
Market revenue in 2030 | USD 18.7 million |
Growth rate | 5.5% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.92% in 2023. Horizon Databook has segmented the Norway implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
According to the Norwegian Cardiac Arrest Registry’s annual report 2021, the incidence of cardiac arrests in Norway was around 86 per 100,000 individuals per year. Around 4,639 out-of-hospital cardiac arrest cases were reported in 2021.
In addition, 21% of the population suffered from CVD. Moreover, as per MedTech Europe 2020, the country’s biventricular device usage was 91 units/million individuals. Furthermore, a favorable healthcare coverage policy aids market growth.
For instance, the country has a universal healthcare facility for its population, and the benefits offered cover a range of medical services. In addition, 85.5% of health expenditure is funded from public sources.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway implantable cardioverter defibrillators market , including forecasts for subscribers. This country databook contains high-level insights into Norway implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account